
### [NCIT:C79951](http://purl.obolibrary.org/obo/NCIT_C79951)
**Label:** Papillary Adenoma

**Subclasses:** [NCIT:C3687](http://purl.obolibrary.org/obo/NCIT_C3687) (Renal Papillary Adenoma), [NCIT:C43602](http://purl.obolibrary.org/obo/NCIT_C43602) (Gallbladder Papillary Adenoma), [NCIT:C39809](http://purl.obolibrary.org/obo/NCIT_C39809) (Type 1 Renal Papillary Adenoma), [NCIT:C46111](http://purl.obolibrary.org/obo/NCIT_C46111) (Thyroid Gland Follicular Adenoma with Papillary Hyperplasia), [NCIT:C5849](http://purl.obolibrary.org/obo/NCIT_C5849) (Extrahepatic Bile Duct Papillary Adenoma), [NCIT:C39810](http://purl.obolibrary.org/obo/NCIT_C39810) (Type 2 Renal Papillary Adenoma), [NCIT:C3494](http://purl.obolibrary.org/obo/NCIT_C3494) (Lung Papillary Adenoma), 

**Class expressions from DL-Learner:**

- Thing 53.35%
- [NCIT:C12849](http://purl.obolibrary.org/obo/NCIT_C12849) (Squamous Cell) and (not ([NCIT:C32542](http://purl.obolibrary.org/obo/NCIT_C32542) (Esophageal Squamous Cell))) 52.94%
- [NCIT:C12849](http://purl.obolibrary.org/obo/NCIT_C12849) (Squamous Cell) 38.30%
- [NCIT:C12849](http://purl.obolibrary.org/obo/NCIT_C12849) (Squamous Cell) and (not ([NCIT:C38759](http://purl.obolibrary.org/obo/NCIT_C38759) (EBV Infection))) 38.30%
- [NCIT:C12849](http://purl.obolibrary.org/obo/NCIT_C12849) (Squamous Cell) and (not ([NCIT:C38732](http://purl.obolibrary.org/obo/NCIT_C38732) (Defective Alpha Heavy Chain Present))) 38.30%
- [NCIT:C12849](http://purl.obolibrary.org/obo/NCIT_C12849) (Squamous Cell) and (not ([NCIT:C38731](http://purl.obolibrary.org/obo/NCIT_C38731) (Villous Atrophy))) 38.30%
- [NCIT:C12849](http://purl.obolibrary.org/obo/NCIT_C12849) (Squamous Cell) and (not ([NCIT:C38730](http://purl.obolibrary.org/obo/NCIT_C38730) (Lymphoepithelial Lesion))) 38.30%
- [NCIT:C12849](http://purl.obolibrary.org/obo/NCIT_C12849) (Squamous Cell) and (not ([NCIT:C38727](http://purl.obolibrary.org/obo/NCIT_C38727) (Villous Lymphocyte))) 38.30%
- [NCIT:C12849](http://purl.obolibrary.org/obo/NCIT_C12849) (Squamous Cell) and (not ([NCIT:C38721](http://purl.obolibrary.org/obo/NCIT_C38721) (Nuclear Pleomorphism))) 38.30%
- [NCIT:C12849](http://purl.obolibrary.org/obo/NCIT_C12849) (Squamous Cell) and (not ([NCIT:C38710](http://purl.obolibrary.org/obo/NCIT_C38710) (Defective Gamma Heavy Chain Present))) 38.30%
- [NCIT:C12849](http://purl.obolibrary.org/obo/NCIT_C12849) (Squamous Cell) and (not ([NCIT:C3870](http://purl.obolibrary.org/obo/NCIT_C3870) (Lymphangitic Carcinomatosis))) 38.30%
- [NCIT:C12849](http://purl.obolibrary.org/obo/NCIT_C12849) (Squamous Cell) and (not ([NCIT:C38698](http://purl.obolibrary.org/obo/NCIT_C38698) (Hyperviscosity))) 38.30%
- [NCIT:C12849](http://purl.obolibrary.org/obo/NCIT_C12849) (Squamous Cell) and (not ([NCIT:C38674](http://purl.obolibrary.org/obo/NCIT_C38674) (Widespread Disease))) 38.30%
- [NCIT:C12849](http://purl.obolibrary.org/obo/NCIT_C12849) (Squamous Cell) and (not ([NCIT:C38667](http://purl.obolibrary.org/obo/NCIT_C38667) (Polymorphic Cellular Infiltrate))) 38.30%
- [NCIT:C12849](http://purl.obolibrary.org/obo/NCIT_C12849) (Squamous Cell) and (not ([NCIT:C38666](http://purl.obolibrary.org/obo/NCIT_C38666) (Monomorphic Cellular Infiltrate))) 38.30%


